Potential clinical application of the cancer antigen CA‑62 for differential diagnosis of prostate cancer and benign prostatic hyperplasia at the elevated prostate‑specific antigen

Purpose of the study. Evaluation of the diagnostic characteristics of the CA‑62 marker for epithelial carcinomas for detecting early‑stage prostate cancer in a double‑blind clinical study. This study is also focused on the possibility of using the CA‑62 antigen as an auxiliary tool for decision‑maki...

Full description

Bibliographic Details
Published in:	Исследования и практика в медицине
Main Authors:	Zh. R. Cherkasova, S. A. Tsurkan, A. I. Prostyakova, A. M. Boroda, A. A. Rozhkov, Yu. N. Pirogova, N. M. Nikitina, M. I. Sekacheva
Format:	Article
Language:	Russian
Published:	QUASAR, LLC 2023-03-01
Subjects:	cancer marker prostate cancer benign prostatic hyperplasia prostate‑specific antigen ca‑62 cancer antigen prostate biopsy
Online Access:	https://www.rpmj.ru/rpmj/article/view/874

Similar Items

Addition of Prostate Volume and Prostate-specific Antigen Density to Memorial Sloan Kettering Cancer Center Prostate Cancer Nomograms
by: Michael Tzeng, et al.
Published: (2021-08-01)

Usefulness of prostate specific antigen density in detecting prostate carcinoma: A hospital-based study in patients with prostate biopsies
by: Reshmi Shrestha, et al.
Published: (2022-03-01)

Prostate Specific Antigen (PSA): The Historical Perspective
by: T. Ming Chu
Published: (2020-12-01)

Benign prostatic hyperplasia and prostate-specific antigen
by: Pejčić Tomislav, et al.
Published: (2015-01-01)

Prostate cancer screening with prostate-specific antigen: A guide to the guidelines
by: Sonja Cabarkapa, et al.
Published: (2016-12-01)

Association between prostate-specific antigen density and prostate cancer prediction among Nigerian men
by: Abudu EK, et al.
Published: (2025-01-01)

What Should Be the Prostate Specific Antigen Threshold for Prostate Biopsy?
by: Hasan Deliktaş, et al.
Published: (2017-06-01)

Comparison of Prostate-Specific Antigen and Its Density and Prostate Health Index and Its Density for Detection of Prostate Cancer
by: Youngjun Boo, et al.
Published: (2023-07-01)

Prostate Specific Antigen Level and Gleason Score in Indonesian Prostate Cancer Patients
by: Muhammad Imam Al Kautsar Herawan, et al.
Published: (2024-09-01)

Prostate-specific antigen and prostate-specific antigen density cutoff points among Indonesian population suspected for prostate cancer
by: Ahmad Anies Shahab, et al.
Published: (2013-03-01)

Research of the best screen interval for middle aged and elderly Chinese males with baseline prostate specific antigen levels <2.0 ng/mL in prostate cancer screening
by: Yu Chen, et al.
Published: (2024-09-01)

Peripheral zone prostate-specific antigen density: an effective parameter for prostate cancer prediction in men receiving 5α-reductase inhibitors
by: Kyo Chul Koo, et al.
Published: (2013-09-01)

Comparison of the pre-treatment testosterone levels in benign prostatic hyperplasia and prostate cancer patients
by: D.E. Orakwe, et al.
Published: (2017-06-01)

Relationship of Prostate-Specific Antigen (PSA) and Prostate Volume in Patients with Biopsy Proven Benign Prostatic Hyperplasia (BPH)
by: Aulia Nur Fadila, et al.
Published: (2020-07-01)

Effect of Antibiotic on Men with Raised Prostatic-Specific Antigen (4-10 ng/ml)
by: Abdulsattar J. Ali, et al.
Published: (2020-12-01)

The impact of exercise on prostate-specific antigen and testosterone in prostate cancer: a systematic review and meta-analysis
by: Fuxun Zhang, et al.
Published: (2025-12-01)

Relationship of age, prostate-specific antigen, and prostate volume in Indonesian men with benign prostatic hyperplasia
by: Ida Bagus O.W. Putra, et al.
Published: (2016-06-01)

The Probability of Metastases Within Different Prostate-specific Antigen Ranges Using Prostate-specific Membrane Antigen Positron Emission Tomography in Patients with Newly Diagnosed Prostate Cancer
by: Wietske I. Luining, et al.
Published: (2024-01-01)

Clinical Issues for Prostate-Specific Antigen Screening: A Narrative Review
by: Marco Randazzo, et al.
Published: (2018-12-01)

Correlation between prostate volume and prostate-specific antigen in patients diagnosed with benign prostatic hyperplasia
by: Udoh EA, et al.
Published: (2020-12-01)

Prostate-Specific Antigen Trends Predict the Probability of Prostate Cancer in a Very Large U.S. Veterans Affairs Cohort
by: R. Jeffrey Karnes, et al.
Published: (2018-08-01)

Effect of Temperature and Humidity on Serum Prostate Specific Antigen Levels in Asymptomatic Male Population
by: Murat Tuğrul Eren, et al.
Published: (2016-12-01)

Prostate-specific antigen response rate of sequential chemotherapy in castration-resistant prostate cancer: the results of real life practice
by: Geehyun Song, et al.
Published: (2013-09-01)

Prostate-specific antigen and risk of bone metastases in west Africans with prostate cancer
by: Yaw Ampem Amoako, et al.
Published: (2019-04-01)

Prostate-specific antigen and risk of bone metastases in west Africans with prostate cancer
by: Yaw Ampem Amoako, et al.
Published: (2019-01-01)

Epidemiological Study of Patients with Prostate Cancer in South of Iraq
by: Manal Badi Salih Al-Tmemi
Published: (2019-07-01)

Serum testosterone and prostate-specific antigen levels are major risk factors for prostatic volume increase among benign prostatic hyperplasia patients
by: Gede Wirya Kusuma Duarsa, et al.
Published: (2021-07-01)

The Impact of the Percent of Residual Prostate-Specific Antigen on Metastasis-Free Survival in Patients with Persistent Prostate-Specific Antigen after Radical Prostatectomy
by: Dan Bee Lee, et al.
Published: (2023-01-01)

Single-lesion Prostate-specific Membrane Antigen Protein Expression (PSMA) and Response to [177Lu]-PSMA-ligand Therapy in Patients with Castration-resistant Prostate Cancer
by: Judith Stangl-Kremser, et al.
Published: (2021-08-01)

The Impact of prostate – Specific Antigen Density In Predicting Prostate Cancer
by: Abdul-Kareem Sh. Al-Khafaji, et al.
Published: (2019-11-01)

The Impact of prostate – Specific Antigen Density In Predicting Prostate Cancer
by: Abdul-Kareem Sh. Al-Khafaji, et al.
Published: (2019-11-01)

Human Prostate-Specific Antigen Carries N-Glycans with Ketodeoxynononic Acid
by: Wei Wang, et al.
Published: (2023-07-01)

Engineered Jurkat Cells for Targeting Prostate-Specific Membrane Antigen on Prostate Cancer Cells by Nanobody-Based Chimeric Antigen Receptor
by: Mahmoud Hassani, et al.
Published: (2020-03-01)

Quaint Metastasis and Markedly Elevated Prostate-Specific Antigen An Unusual Manifestation of Prostate Cancer
by: Nwachukwu Olusegun Nwachukwu, et al.
Published: (2022-07-01)

Prostate-specific antigen kinetics after stereotactic body radiotherapy as monotherapy or boost after whole pelvic radiotherapy for localized prostate cancer
by: Hun Jung Kim, et al.
Published: (2015-12-01)

Incidence of prostate adenocarcinoma in transurethral resection of the prostate patients
by: Yahia Ghazwani, et al.
Published: (2025-01-01)

Evaluating whether Prostate Cancer UK’s risk checker is a help or hindrance to prostate-specific antigen testing policy: a mixed-methods study
by: Natalia Norori, et al.
Published: (2024-07-01)

PSA density in the diagnosis of prostate cancer in the Chinese population: results from the Chinese Prostate Cancer Consortium
by: Zi-Jian Song, et al.
Published: (2021-01-01)

Prostate-specific antigen kinetics in hypofractionated radiation therapy alone for intermediate- and high-risk localized prostate cancer
by: Tae Hoon Lee, et al.
Published: (2023-09-01)

Current biomarkers of prostate cancer
by: I. A. Aboian, et al.
Published: (2021-12-01)